Search Results 821-830 of 14798 for anti-TNF drugs

  1. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or ...

  2. Tacrine (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Rozanolixizumab-Noli (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Natamycin (Ophthalmic Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Serum Metabolomics - Migraine Research Program - Mayo Clinic Research

    If successful, the program will use the knowledge to push forward the development of drugs that exert only the relevant anti-migraine effect(s). These would ...

  6. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Efavirenz, Lamivudine, And Tenofovir (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Symfi; Symfi Lo. Descriptions.

  8. Nadolol And Bendroflumethiazide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Mayo Clinic Studying Genomics of Antiplatelet Heart Medication

    “This study will tell us whether this gene plays an important role in determining response to anti-platelet therapy after coronary interventions.” Michael ...

  10. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... adalimumab, certolizumab, etanercept, golimumab, infliximab, abatacept ...